Physician profile
Danielle White
NPI 1134696396
$7,799.38
in general payments reported to CMS, 2019-2025
34 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,542 · 2023: $3,392 · 2024: $2,602 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,257.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,257.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,042.76 | 2022-2025 | |
| Lilly USA, LLC | $982.52 | 2022-2024 | Mounjaro, Jardiance, Trulicity |
| Astrazeneca Pharmaceuticals Lp | $941.23 | 2022-2024 | Farxiga, Breztri, Tagrisso |
| Pfizer INC. | $720.95 | 2022-2025 | |
| Novo Nordisk INC | $578.50 | 2022-2024 | Ozempic, Rybelsus, Wegovy |
| Novartis Pharmaceuticals Corporation | $389.46 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $356.74 | 2022-2024 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $347.14 | 2022-2025 | |
| Abbott Laboratories | $272.27 | 2023-2025 | Freestyle Libre 3, Freestyle Libre 2 |
| E.R. Squibb & Sons, L.L.C. | $212.56 | 2022-2024 | Eliquis |
| Amgen INC. | $211.35 | 2024-2025 | Repatha, Otezla, Repatha |
| Phathom Pharmaceuticals, INC. | $170.61 | 2024-2025 | Voquezna |
| Exact Sciences Corporation | $161.34 | 2023-2024 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $157.44 | 2022-2024 | Spravato |
| Sumitomo Pharma America, INC. | $156.22 | 2023-2024 | Gemtesa |
Show all 34 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle White listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.